Study of Compound Edaravone Injection for Treatment of Acute Ischemic Stroke
Clinical trial NCT04984577 · SUSPENDED
Trial details
- NCT number
- NCT04984577
- Sponsor
- Nanjing Yoko Biomedical Co., Ltd.
- Status
- SUSPENDED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-15
- Primary completion
- 2026-12-31
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.